Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    enVVeno Medical Corporati...

    NASDAQ: NVNO · Real-Time Price · USD
    4.46
    0.12 (2.76%)
    At close: Jun 16, 2025, 3:59 PM
    4.41
    -1.12%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    enVVeno Medical Statistics

    Share Statistics

    enVVeno Medical has 17.54M shares outstanding. The number of shares has increased by 31.55% in one year.

    Shares Outstanding

    n/a
    		 17.54M

    Shares Change (YoY)

    n/a
    		 31.55%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 26.53%

    Shares Floating

    n/a
    		 17.37M

    Failed to Deliver (FTD) Shares

    n/a
    		 31

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 471.62K, so 2.69% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 471.62K

    Short % of Shares Out

    n/a
    		 2.69%

    Short % of Float

    n/a
    		 2.7%

    Short Ratio (days to cover)

    n/a
    		 7.41

    Valuation Ratios

    The PE ratio is -2.37 and the forward PE ratio is -4.34. enVVeno Medical's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -2.37

    Forward PE

    n/a
    		 -4.34

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.7

    PB Ratio

    n/a
    		 1.23

    P/FCF Ratio

    n/a
    		 -3.07

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for enVVeno Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 20.88, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 20.88

    Quick Ratio

    n/a
    		 20.88

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.06

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-589,702.7

    Employee Count

    n/a
    		 37

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -8.79% in the last 52 weeks. The beta is 0.92, so enVVeno Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.92

    52-Week Price Change

    n/a
    		 -8.79%

    50-Day Moving Average

    n/a
    		 3.29

    200-Day Moving Average

    n/a
    		 3.41

    Relative Strength Index (RSI)

    n/a
    		 64.25

    Average Volume (20 Days)

    n/a
    		 97,700

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -23.83M

    Net Income

    n/a
    		 -21.82M

    EBITDA

    n/a
    		 -21.29M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.27
    Full Income Statement

    Balance Sheet

    The company has 1.75M in cash and 1.06M in debt, giving a net cash position of 690K.

    Cash & Cash Equivalents

    n/a
    		 1.75M

    Total Debt

    n/a
    		 1.06M

    Net Cash

    n/a
    		 690K

    Retained Earnings

    n/a
    		 -151.85M

    Total Assets

    n/a
    		 40.58M

    Working Capital

    n/a
    		 37.82M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -16.84M and capital expenditures -37K, giving a free cash flow of -16.88M.

    Operating Cash Flow

    n/a
    		 -16.84M

    Capital Expenditures

    n/a
    		 -37K

    Free Cash Flow

    n/a
    		 -16.88M

    FCF Per Share

    n/a
    		 -0.98
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NVNO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for NVNO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 30, 2020. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Nov 30, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 11.32

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist